World of DTC Marketing

MAY 16, 2022

Mounjaro, Lilly’s new diabetes drug, is sure to be in high demand initially after launch, but patients should be aware of its side effects. According to Lilly side, the effects include “Mounjaro may cause tumors in the thyroid, including thyroid cancer and Inflammation of the pancreas (pancreatitis).”

Food and Drug Administration 218

Food and Drug Administration Side effects Pharma Patients 218

World of DTC Marketing

JULY 17, 2022

A Harvard study found that almost half of Americans are expected to be obese by 2030, accounting for up to 18 percent of healthcare spending on related conditions, ranging from heart disease and stroke to osteoarthritis. . Novo Nordisk more than doubled its sales targets for obesity drugs to $3.7bn by 2025.

Side effects 209

Side effects Doctors Insurance Prescription 209

World of DTC Marketing

JANUARY 7, 2021

By 2030, low retention will, on average, cost the US $430 billion annually. The title-seeking job hoppers will always be a pharma side-effect, but who within the big matrix organizations are really trying to change the way they do business every day? Employee retention rates hit a record low in March 2020.

Pharma 215

Pharma Side effects Distribution Consulting 215

Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% GnRH antagonists have an improved safety and efficacy profile compared to the marketed GnRH agonists, which have significant side effects that are unappealing to patients. of 7MM sales.

Marketing 59

Marketing Side effects Sales Safety 59

European Pharmaceutical Review

OCTOBER 24, 2024

Nevertheless, both efficiently clear amyloid and have a similar slowing effect on progression of cognitive decline in patients”. However, side effects of these drugs, such as “the development of amyloid-related imaging abnormalities (ARIAs), remains a significant concern”. billion in 2030, respectively.” billion and $2.0

Food and Drug Administration 52

Food and Drug Administration Side effects Medicine Patients 52

Medico Reach

FEBRUARY 8, 2023

from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. The Emergence of the Pharmacovigilance Market Medicines and vaccines often have unwanted and severe side effects. from 2023 to 2030. Poised to grow at a CAGR of 29.4% The global pharmacovigilance (PV) market stood at USD 7.80

Pharma 52

Pharma Medicine Marketing Prospecting 52

pharmaphorum

SEPTEMBER 30, 2022

GlobalData notes that the side effect could be a barrier for lecanemab use as it will require patient monitoring, but points out that the rates are a “significant improvement” on Aduhelm, which had an ARIA-E rate of 35% of patients taking the approved dose in clinical trials. .”

Doctors 52

Doctors Side effects Sales Safety 52